期 |
栏目 |
标题 |
文件 |
卷 2, 编号 1 (2000) |
Articles |
Arimideks - novyy nesteroidnyy selektivnyy ingibitor aromatazy Predvaritel'nye rezul'taty "Otkrytogo nesravnitel'nogo issledovaniya po otsenke effektivnosti i perenosimosti arimideksa ( 1 mg) pri lechenii rasprostranennogo raka molochnoy zhelezy u zhenshchin |
|
卷 2, 编号 4 (2000) |
Articles |
Lekarstvennoe lechenie raka yaichnikov: standarty i perspektivy |
|
卷 3, 编号 1 (2001) |
Articles |
Izuchenie effektivnosti i bezopasnosti tomudeksa * v 1 - y linii terapii u bol'nykh rasprostranennym kolorektal'nym rakom |
|
卷 3, 编号 2 (2001) |
Articles |
Gemzar (gemtsitabin) v lechenii nemelkokletochnogo raka legkogo |
|
卷 3, 编号 4 (2001) |
Articles |
Ftorafur - pervyy peroral'nyy ftorpirimidin v terapii metastaticheskogo kolorektal'nogo raka |
|
卷 4, 编号 1 (2002) |
Articles |
Geksalen v novykh kombinatsiyakh s gemzarom ili vepezidom pri platino-taksano-rezistentnykh formakh raka yaichnikov |
|
卷 4, 编号 1 (2002) |
Articles |
Anastrozol kak perspektiva ad\"yuvantnogo lecheniya raka molochnoy zhelezy u bol'nykh v menopauze |
|
卷 4, 编号 3 (2002) |
Articles |
Anemiya pri zlokachestvennykh opukholyakh |
|
卷 4, 编号 4 (2002) |
Articles |
Topotekan v kachestve II linii khimioterapii raka yaichnikov |
|
卷 4, 编号 4 (2002) |
Articles |
Vozmozhnosti ispol'zovaniya taksotera pri razlichnykh solidnykh opukholyakh |
|
卷 4, 编号 4 (2002) |
Articles |
Osobennosti lecheniya bol'noy neorgannoy pleomorfnoy liposarkomoy |
|
卷 5, 编号 1 (2003) |
Articles |
Opyt primeneniya abitaksela™ v lechenii solidnykh opukholey |
|
卷 5, 编号 4 (2003) |
Articles |
Rasshirenie spektra terapevticheskikh vozmozhnostey oksaliplatina |
|
卷 6, 编号 2 (2004) |
Articles |
Khimioterapiya nemelkokletochnogo raka legkogo: vybor pervoy linii |
|
卷 7, 编号 2 (2005) |
Articles |
Farmorubitsin v klinicheskoy praktike |
|
卷 8, 编号 1 (2006) |
Articles |
Opyt primeneniya Taksotera v kombinatsii s doksorubitsinom v kachestve khimioterapii 1-y linii u bol'nykh metastaticheskim rakom molochnoy zhelezy |
|
卷 9, 编号 1 (2007) |
Articles |
Ul'trazvukovye kriterii effektivnosti lecheniya raka yaichnikov |
|
卷 9, 编号 3 (2007) |
Articles |
Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei |
|
卷 10, 编号 3 (2008) |
Articles |
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy |
|
卷 11, 编号 3 (2009) |
Articles |
Primenenie Aranozy pri neyroendokrinnykh opukholyakh |
|
卷 11, 编号 3 (2009) |
Articles |
Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy |
|
卷 12, 编号 1 (2010) |
Articles |
Sovremennye napravleniya lecheniyaneyroendokrinnykh opukholey |
|
卷 12, 编号 3 (2010) |
Articles |
Vozmozhnosti khimioterapii rakamolochnoy zhelezy, rezistentnogok antratsiklinam i taksanam |
|
卷 12, 编号 3 (2010) |
Articles |
Izuchenie gemtsitabina (Gemzar®)i tsisplatina v pervoy linii terapiirasprostranennogo raka yaichnika(issledovanie II fazy) |
|
卷 12, 编号 3 (2010) |
Articles |
Primenenie preparata sorafenibpri lechenii gepatotsellyulyarnoy kartsinomy(Obzor klinicheskikh i neinterventsionnykhissledovaniy: issledovanie GIDEON) |
|
卷 12, 编号 3 (2010) |
Articles |
Trabektedin v lekarstvennom lecheniisarkom myagkikh tkaney |
|
卷 12, 编号 3 (2010) |
Articles |
Astenicheskie rasstroystva,assotsiirovannye s khimioterapieyzlokachestvennykh novoobrazovaniy(Obzor literatury) |
|
卷 13, 编号 2 (2011) |
Articles |
Klinicheskie rekomendatsii po profilaktikei lecheniyu toshnoty i rvoty u bol'nykh,poluchayushchikh khimio- i luchevuyuprotivoopukholevuyu terapiyu |
|
卷 15, 编号 4 (2013) |
Articles |
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer |
|
卷 16, 编号 2 (2014) |
Articles |
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board |
|
卷 16, 编号 3 (2014) |
Articles |
Avastin in clinical chemotherapy of malignant tumors |
|
卷 16, 编号 2 (2014) |
Articles |
Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case |
|
卷 16, 编号 2 (2014) |
Articles |
Prognostic significance of dynamics of biochemical markers of neuroendocrine tumors during treatment with biotherapy |
|
卷 17, 编号 4 (2015) |
Articles |
Modern possibilities of targeted therapy in metastatic colorectal cancer |
|
卷 17, 编号 3 (2015) |
Articles |
Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors |
|
卷 18, 编号 1 (2016) |
Articles |
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) |
(Rus)
|
卷 18, 编号 1 (2016) |
Articles |
Lanreotide for the treatment of patients with disseminated high-grade neuroendocrine tumors: the experience of application in case of unsatisfactory tolerability of octreotide |
(Rus)
|
卷 18, 编号 3 (2016) |
Articles |
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia |
(Rus)
|
卷 18, 编号 3 (2016) |
Articles |
Modern therapy of radioactive iodine-refractory differentiated thyroid cancer: resolution of the Expert Council |
(Rus)
|
卷 19, 编号 3 (2017) |
Articles |
The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation |
(Rus)
|
卷 19, 编号 2 (2017) |
Articles |
Interferon α (IFN-α) vs. the combination IFN-α and octreotide LAR in the treatment of patients with well differentiated neuroendocrine tumors (NET) of various localizations |
(Rus)
|
卷 13, 编号 1 (2011) |
Articles |
Izmenenie podkhoda k lecheniyu platinochuvstvitel'nykh retsidivov raka yaichnikov |
|
卷 13, 编号 3 (2011) |
Articles |
Neyroendokrinnye opukholizheludochno-kishechnogo traktai podzheludochnoy zhelezy. Printsipysistemnoy terapii (opyt lecheniya) |
|
卷 20, 编号 3 (2018) |
Articles |
The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156 |
(Rus)
|